The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Impulse Control Disorders in Parkinson Disease: A Cross-Sectional Study of 3090 Patients
Abstract
CONTEXT: An association between dopamine-replacement therapies and impulse control disorders (ICDs) in Parkinson disease (PD) has been suggested in preliminary studies. OBJECTIVES: To ascertain point prevalence estimates of 4 ICDs in PD and examine their associations with dopamine-replacement therapies and other clinical characteristics. DESIGN: Cross-sectional study using an a priori established sampling procedure for subject recruitment and raters blinded to PD medication status. PATIENTS: Three thousand ninety patients with treated idiopathic PD receiving routine clinical care at 46 movement disorder centers in the United States and Canada. MAIN OUTCOME MEASURES: The Massachusetts Gambling Screen score for current problem/pathological gambling, the Minnesota Impulsive Disorders Interview score for compulsive sexual behavior and buying, and Diagnostic and Statistical Manual of Mental Disorders research criteria for binge-eating disorder. RESULTS: An ICD was identified in 13.6% of patients (gambling in 5.0%, compulsive sexual behavior in 3.5%, compulsive buying in 5.7%, and binge-eating disorder in 4.3%), and 3.9% had 2 or more ICDs. Impulse control disorders were more common in patients treated with a dopamine agonist than in patients not taking a dopamine agonist (17.1% vs 6.9%; odds ratio [OR], 2.72; 95% confidence interval [CI], 2.08-3.54; P < .001). Impulse control disorder frequency was similar for pramipexole and ropinirole (17.7% vs 15.5%; OR, 1.22; 95% CI, 0.94-1.57; P = .14). Additional variables independently associated with ICDs were levodopa use, living in the United States, younger age, being unmarried, current cigarette smoking, and a family history of gambling problems. CONCLUSIONS: Dopamine agonist treatment in PD is associated with 2- to 3.5-fold increased odds of having an ICD. This association represents a drug class relationship across ICDs. The association of other demographic and clinical variables with ICDs suggests a complex relationship that requires additional investigation to optimize prevention and treatment strategies. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00617019.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Unified Parkinson's Disease Rating Scale
(2012) · SpringerReference · doi:10.1007/springerreference_184495 · Cited by 3,066
Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale
Fahn, S. (1987) · Medical Entomology and Zoology · Cited by 2,163
Shaffer, H. J., Hall, M. N., & Vander Bilt, J. (1999) · American Journal of Public Health · doi:10.2105/ajph.89.9.1369 · Cited by 1,253
Petry, N. M., Stinson, F. S., & Grant, B. F. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0504 · Cited by 1,245 · cited 1×
“Elevated frequencies of tobacco smoking have been reported in association with ICDs in the general population.(29) This finding, in conjunction with the association of a family history of gambling problems, is consistent with the proposition that there are shared neurobiological, genetic, or environmental contribution…”
Result'Behavioral' Addictions: Do They Exist?
Holden, C. (2001) · Science · doi:10.1126/science.294.5544.980 · Cited by 746
Compulsive buying: descriptive characteristics and psychiatric comorbidity.
Ga, C., Faber, R., de Zwaan, M., Raymond, N. C., Sm, S., Ekern, Tb, M., Crosby, R. D., Sj, C., & Ed, E. (1994) · PubMed · Cited by 664
Association of dopamine agonist use with impulse control disorders in Parkinson disease
Weintraub, D., Siderowf, A. D., Potenza, M. N., Goveas, J., Morales, K. H., Duda, J. E., Moberg, P. J., & Stern, M. B. (2006) · Archives of Neurology · doi:10.1001/archneur.63.7.969 · Cited by 662 · cited 2×
“In this study, after controlling for levodopa exposure and other covariates, no dopamine agonist dosing effect was found, though there are reports to the contrary.(2,16) As the study was crosssectional, a selection bias for current dopamine agonist dosage may have existed that obscured a dosing effect (eg, patients wi…”
BackgroundResultSelf-citationGiovannoni, G. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.4.423 · Cited by 587
Estimated Prevalence of Compulsive Buying Behavior in the United States
Koran, L. M., Faber, R. J., Aboujaoude, E., Large, M. D., & Serpe, R. T. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.10.1806 · Cited by 553
The neurobiology and genetics of impulse control disorders: Relationships to drug addictions
Brewer, J. A., & Potenza, M. N. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.043 · Cited by 511
Self-citationCunningham-Williams, R. M., Cottler, L. B., Compton, W. M., & Spitznagel, E. L. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.7.1093 · Cited by 473
Common Genetic Vulnerability for Pathological Gambling and Alcohol Dependence in Men
Slutske, W. S. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.7.666 · Cited by 441
Gurevich, E. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00066-9 · Cited by 431
Prevalence of repetitive and reward-seeking behaviors in Parkinson disease
Voon, V., Hassan, K., Zurowski, M., de Souza, M., Thomsen, T., Fox, S., Lang, A. E., & Miyasaki, J. (2006) · Neurology · doi:10.1212/01.wnl.0000238503.20816.13 · Cited by 418
Self-citationPunding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome
Evans, A., Katzenschlager, R., Paviour, D. C., Appel‐Cresswell, S., Lawrence, A., & Lees, A. J. (2004) · UCL Discovery (University College London) · Cited by 401
Medication-Related Impulse Control and Repetitive Behaviors in Parkinson Disease
Voon, V., & Fox, S. H. (2007) · Archives of Neurology · doi:10.1001/archneur.64.8.1089 · Cited by 397
Self-citationPrevalence and correlates of binge eating disorder in a community sample
Grucza, R. A., Przybeck, T. R., & Cloninger, C. R. (2007) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2006.08.002 · Cited by 379
Prospective prevalence of pathologic gambling and medication association in Parkinson disease
Voon, V., Hassan, K., Zurowski, M., Duff-Canning, S., de Souza, M., Fox, S., Lang, A. E., & Miyasaki, J. (2006) · Neurology · doi:10.1212/01.wnl.0000218206.20920.4d · Cited by 329
Self-citationPathological gambling associated with dopamine agonist therapy in Parkinson’s disease
Driver-Dunckley, E., Samanta, J., & Stacy, M. (2003) · Neurology · doi:10.1212/01.wnl.0000076478.45005.ec · Cited by 313
Self-citationFactors Associated With Dopaminergic Drug–Related Pathological Gambling in Parkinson Disease
Voon, V., Thomsen, T., Miyasaki, J. M., de Souza, M., Shafro, A., Fox, S. H., Duff-Canning, S., Lang, A. E., & Zurowski, M. (2007) · Archives of Neurology · doi:10.1001/archneur.64.2.212 · Cited by 311
Self-citationEpidemiology, Prevalence, and Natural History of Compulsive Sexual Behavior
Kuzma, J. M., & Black, D. W. (2008) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2008.06.005 · Cited by 276
Comings, D. E., Gonzalez, N., Wu, S., Gade, R., Muhleman, D., Saucier, G., Johnson, P., Verde, R., Rosenthal, R. J., Lesieur, H. R., et al. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990820)88:4<358::aid-ajmg13>3.0.co;2-g · Cited by 276
Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease
Smeding, H. M. M., Goudriaan, A. E., Foncke, E. M. J., Schuurman, P. R., Speelman, J. D., & Schmand, B. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.102061 · Cited by 254
Pathologic gambling in Parkinson's disease: A behavioral manifestation of pharmacologic treatment?
Molina, J. A., S�inz-Artiga, M. J., Fraile, A., Jim�nez-Jim�nez, F. J., Villanueva, C., Ort�-Pareja, M., & Bermejo-P, F. (2000) · Movement Disorders · doi:10.1002/1531-8257(200009)15:5<869::aid-mds1016>3.0.co;2-i · Cited by 253
Pathological gambling among adolescents: Massachusetts Gambling Screen (MAGS)
Shaffer, H. J., LaBrie, R., Scanlan, K. M., & Cummings, T. N. (1994) · Journal of Gambling Studies · doi:10.1007/bf02104901 · Cited by 240
Epidemiology of binge eating disorder
Striegel-Moore, R. H., & Franko, D. L. (2003) · International Journal of Eating Disorders · doi:10.1002/eat.10202 · Cited by 230
Clinical features associated with impulse control disorders in Parkinson disease
Pontone, G., Williams, J. R., Bassett, S. S., & Marsh, L. (2006) · Neurology · doi:10.1212/01.wnl.0000238401.76928.45 · Cited by 219
Predictors of impulsivity and reward seeking behavior with dopamine agonists
Ondo, W. G., & Lai, D. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2007.05.006 · Cited by 195
Gerlach, M., Double, K., Arzberger, T., Leblhuber, F., Tatschner, T., & Riederer, P. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0027-5 · Cited by 187
Giladi, N., Weitzman, N., Schreiber, S., Shabtai, H., & Peretz, C. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106073109 · Cited by 164
Prevalence of pathological gambling in patients with Parkinson's disease
Avanzi, M., Baratti, M., Cabrini, S., Uber, E., Brighetti, G., & Bonfà, F. (2006) · Movement Disorders · doi:10.1002/mds.21072 · Cited by 159
Impulse Control Disorder Behaviors Associated with Pramipexole Used to Treat Fibromyalgia
Holman, A. J. (2009) · Journal of Gambling Studies · doi:10.1007/s10899-009-9123-2 · Cited by 79
Singh, A., Kandimala, G., Dewey, R. B., & O’Suilleabhain, P. E. (2007) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2007.01.009 · Cited by 76
A family history study of binge-eating disorder
Lilenfeld, L., Ringham, R. M., Kalarchian, M. A., & Marcus, M. D. (2007) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2007.10.001 · Cited by 59
Prevalence of Problem and Pathological Gambling in Parkinson’s Disease
Crockford, D. N., Quickfall, J., Currie, S. R., Furtado, S., Suchowersky, O., & el‐Guebaly, N. (2008) · Journal of Gambling Studies · doi:10.1007/s10899-008-9099-3 · Cited by 59
Prevalence of repetitive and rewardseeking behaviors in Parkinson disease
Verma, A. (2007) · Yearbook of Neurology and Neurosurgery · doi:10.1016/s0513-5117(08)70073-5 · Cited by 34
Cited by
Pharmacological Treatment of Parkinson Disease: A Review
Connolly, B. S., & Lang, A. E. (2014) · JAMA · doi:10.1001/jama.2014.3654 · Cited by 1,498
Self-citationSeppi, K., Weintraub, D., Coelho, M., Perez‐Lloret, S., Fox, S. H., Katzenschlager, R., Hametner, E., Poewe, W., Rascol, O., Goetz, C. G., et al. (2011) · Movement Disorders · doi:10.1002/mds.23884 · Cited by 1,141
“Weintraub et al. (2010)19 conducted an 8-week, randomized, placebo-controlled study of atomoxetine (an NRI) for the treatment of clinically significant depressive symptoms in 55 subjects with PD and moderate depression as defined by a score of 22 on the Inventory of Depressive…”
MethodSelf-citationObeso, J. A., Stamelou, M., Goetz, C. G., Poewe, W., Lang, A. E., Weintraub, D., Burn, D., Halliday, G. M., Bezard, E., Przedborski, S., et al. (2017) · Movement Disorders · doi:10.1002/mds.27115 · Cited by 859
Self-citationParkinson’s Disease in Women and Men: What’s the Difference?
Cerri, S., Mus, L., & Blandini, F. (2019) · Journal of Parkinson’s Disease · doi:10.3233/jpd-191683 · Cited by 800
Circuit Mechanisms of Parkinson’s Disease
McGregor, M. M., & Nelson, A. B. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.004 · Cited by 624
Metadata
- Authors
- Weintraub, D., Koester, J., Potenza, M. N., Siderowf, A. D., Stacy, M., Voon, V., Whetteckey, J., Wunderlich, G. R., & Lang, A. E.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2010-05-01
- Volume
- 67
- Issue
- 5
- Pages
- 589-95
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2098445519
- Cited by
- 1,487
- References
- 37
- FWCI
- 66.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.